Rasti A - Search Results

1

Human telomerase reverse transcriptase protein expression predicts tumour aggressiveness and survival in patients with clear cell renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Rasti A, Shariftabrizi A, Mehrazma M, Fodstad Ø, Asgari M. Saeednejad Zanjani L, et al. Among authors: rasti a. Pathology. 2019 Jan;51(1):21-31. doi: 10.1016/j.pathol.2018.08.019. Epub 2018 Nov 19. Pathology. 2019. PMID: 30466948

2

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol.

Rasti A, Mehrazma M, Madjd Z, Keshtkar AA, Roudi R, Babashah S. Rasti A, et al. BMJ Open. 2016 Jan 4;6(1):e009667. doi: 10.1136/bmjopen-2015-009667. BMJ Open. 2016. PMID: 26729387 Free PMC article.

3

Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma.

Rasti A, Abolhasani M, Zanjani LS, Asgari M, Mehrazma M, Madjd Z. Rasti A, et al. J Cancer Res Clin Oncol. 2017 Jan;143(1):95-104. doi: 10.1007/s00432-016-2239-8. Epub 2016 Sep 16. J Cancer Res Clin Oncol. 2017. PMID: 27638770

4

Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Andersson Y, Rasti A, Shariftabrizi A, Asgari M. Saeednejad Zanjani L, et al. Among authors: rasti a. Exp Mol Pathol. 2017 Oct;103(2):218-228. doi: 10.1016/j.yexmp.2017.10.001. Epub 2017 Oct 16. Exp Mol Pathol. 2017. PMID: 29050853

5

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.

Gheytanchi E, Madjd Z, Janani L, Rasti A, Ghods R, Atyabi F, Asadi-Lari MH, Babashah S. Gheytanchi E, et al. Among authors: rasti a. Syst Rev. 2017 Nov 17;6(1):228. doi: 10.1186/s13643-017-0624-2. Syst Rev. 2017. PMID: 29149908 Free PMC article.

6

Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.

Rasti A, Madjd Z, Abolhasani M, Mehrazma M, Janani L, Saeednejad Zanjani L, Asgari M. Rasti A, et al. Clin Exp Med. 2018 May;18(2):177-190. doi: 10.1007/s10238-017-0481-2. Epub 2017 Dec 4. Clin Exp Med. 2018. PMID: 29204790

7

Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma.

Zanjani LS, Madjd Z, Abolhasani M, Rasti A, Fodstad O, Andersson Y, Asgari M. Zanjani LS, et al. Among authors: rasti a. Biomark Med. 2018 Jan;12(1):45-61. doi: 10.2217/bmm-2017-0142. Epub 2017 Dec 15. Biomark Med. 2018. PMID: 29243496

8

Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol.

Mansoori M, Madjd Z, Janani L, Rasti A. Mansoori M, et al. Among authors: rasti a. Syst Rev. 2017 Dec 19;6(1):262. doi: 10.1186/s13643-017-0660-y. Syst Rev. 2017. PMID: 29258583 Free PMC article.

9

Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.

Saeednejad Zanjani L, Madjd Z, Abolhasani M, Shariftabrizi A, Rasti A, Asgari M. Saeednejad Zanjani L, et al. Among authors: rasti a. Cancer Biomark. 2018;21(4):821-837. doi: 10.3233/CBM-170755. Cancer Biomark. 2018. PMID: 29286924

10

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.

Rasti A, Mehrazma M, Madjd Z, Abolhasani M, Saeednejad Zanjani L, Asgari M. Rasti A, et al. Sci Rep. 2018 Aug 6;8(1):11739. doi: 10.1038/s41598-018-30168-4. Sci Rep. 2018. PMID: 30082842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters